State deregulation of open-heart surgery beneficial to patients

October 3, 2012

(Medical Xpress)—Certificate of Need, a form of state government regulation designed to keep mortality rates and health care costs down, appears to do neither for heart bypass surgery, according to a health economics researcher at Rice University and Baylor College of Medicine (BCM). Her findings are reported in an article appearing in today's online edition of the journal Medical Care Research and Review.

Lead author Vivian Ho, the chair in at Rice University's Baker Institute for Public Policy and a professor of medicine at BCM, found that states that removed Certificate ofNeed regulations experienced a 4 percent decrease in the average cost of patient care. These regulations are designed to prevent hospitals that do not treat a minimum prescribed volume of patients from offering open-heart surgery.

"We discovered in a previous study that states that removed Certificate of Need regulations for open-heart surgery experienced no change in patient mortality," Ho said. "Now that we have learned that the cost of patient care is also lower after deregulation, I am doubtful of the value of these regulations."

Currently 25 states maintain Certificate of Need regulations for open-heart surgery, including Georgia, Maryland, New York and Washington. Ho's study evaluated bypass in 34 states, seven of which removed Certificate of Need regulations during her study period between 1991 and 2002. (Only two more states have deregulated open-heart surgery since then.) Deregulation led to more hospitals building new facilities to perform open-heart surgery, which raises costs. However, the cost savings from lowering average costs per patient outweighed the additional costs of these new facilities.

Ho speculated that cost savings result from deregulation because competition encourages hospitals to deliver higher . "The desire to attract more patients in a competitive market leads hospitals to offer higher quality care," Ho said. "It may soundcounterintuitive, but recent studies show that higher quality surgery lowers costs because costly hospital complications are avoided when one improves care."

Ho believes that the results should serve as a lesson to policymakers as they consider the future of Certificate of Need regulations as well as other regulations of the health care system.

Explore further: Adult congenital heart patients with highest surgery costs more likely to die in hospital

More information: "State Deregulation and Medicare Costs for Acute Cardiac Care," Medical Care Research and Review.

Related Stories

Adult congenital heart patients with highest surgery costs more likely to die in hospital

October 18, 2011
Higher surgical costs for adult congenital heart patients is associated with higher rates of inpatient death compared to surgical admissions that incur lower costs, according to a study in Circulation: Quality and Outcomes, ...

Open heart surgery for kidney disease patients

May 17, 2012
One type of open heart surgery is likely safer than the other for chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Patients fare just as well if their nonemergency angioplasty is performed at hospitals

November 14, 2011
Hospitals that do not have cardiac surgery capability can perform nonemergency angioplasty and stent implantation as safely as hospitals that do offer cardiac surgery. That is the finding of the nation's first large, randomized ...

Recommended for you

Half of people aged 40-54 have hardened arteries: study

December 11, 2017
Half of middle-aged people who are normal weight and don't smoke or have diabetes may have clogged arteries, researchers said Thursday, urging stronger measures to lower cholesterol.

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

One-dose gene therapy produces clotting factor, safely stops bleeding in hemophilia B patients

December 6, 2017
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment ...

Clot-busting drugs not recommended for most patients with blood clots

December 6, 2017
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.

Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds

December 5, 2017
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia ...

Blood pressure declines 14 to 18 years before death

December 4, 2017
Blood pressure in the elderly gradually begins to decrease about 14 or so years before death, according to a new study published today in the JAMA Internal Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.